CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

How Digital Technologies Revamp Drug Development Process

Life Sciences Review | Wednesday, April 08, 2020
Tweet

Life sciences companies are looking to implement a digital health strategy that can leverage patient-generated data from increasingly ubiquitous devices.


FREMONT, CA: Digital health is not only transforming the way patient data is gathered in healthcare, but it is disrupting the way the life sciences industry collects data from clinical trial participants. By equipping participants with wearable and medical devices, sensors, and mobile applications, life sciences companies can remotely gather activity data, along with vital biometrics. This stands to restructure the drug development process significantly, enabling companies to bring a drug to market more efficiently and cost-effectively while also enhancing the clinical trial participants’ experience by lowering the number of in-person visits and mitigating the need for manual tracking of data. Read on to know more.


Pharmaceutical companies face three significant challenges in recruiting participants for clinical trials; they are time, money, and ROI. Recruitment and enrollment take about one-third of the time allocated to the clinical trial, and most trials must extend their timelines because of difficulties finding enough patients. The majority of clinical trials do not enroll the target number of patients within the specified time. 


Enrollment times usually take twice as long as projected, which drives up drug development costs.


Digital health tools offer new options that may turn these discouraging numbers around. It is useful to track their activity using wearable devices. The process is remarkably seamless and showed a significant population of patients who were willing to self-quantify and share mobility data. Others have found digital health devices are useful for recruiting large people who are willing to participate in future trials and studies to help identify new research areas.  Wearable devices allow consumers to passively track their health data round the clock, including when they are sleeping, which makes sure the accuracy and timeliness of the information. With growing consumer adoption and the engagement wearable devices offer, they are the central point of a paradigm shift in clinical trials.


Digital health tools can also be harnesses to offer contextual information around prescription therapies, allowing researchers to better evaluate drug performance. Shortly, wearable devices will also be able to decide a participant’s adherence to the medication. In short, digital health can revolutionize how pharmaceutical and contract research organizations conduct the drug development process.


See Also: Top drug Discovery and Development solution Companies


Weekly Brief

loading
Towards a New World Order
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

The Importance of Technology in Multinational Clinical Research

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/how-digital-technologies-revamp-drug-development-process-nwid-116.html